Literature DB >> 552294

Effects of subjects' sex, and intake of tobacco, alcohol and oral contraceptives on plasma phenytoin levels.

E A De Leacy, C D McLeay, M J Eadie, J H Tyrer.   

Abstract

1. Steady state plasma phenytoin levels in 210 epileptic patients were studied by computerized analysis of covariance to determine whether the subject's sex, alcohol intake, tobacco smoking or use of oral contraceptives influenced the relation between plasma drug level and drug dose. 2. Sex, tobacco smoking and alcohol usage had no statistically significant effect. There was a trend towards higher phenytoin levels relative to drug dose in oral contraceptive users. 3. This finding prompted an additional study of plasma phenytoin levels in 40 oral contraceptive users and 135 aged matched non-users. Analysis of covariance again showed higher plasma phenytoin levels relative to drug dose in users of oral contraceptives (P = 0.061). 4. This finding raised the possibility that the relation between plasma phenytoin level and drug dose differed between males and females who did not use oral contraceptives. However, when the relation between plasma phenytoin levels and drug dose was compared in 159 females who did not use oral contraceptives and 101 males (both groups aged 15 to 70 years) no statistically significant difference was found.

Entities:  

Keywords:  Age Factors; Behavior; Contraception; Contraceptive Methods--side effects; Correlation Studies; Demographic Factors; Family Planning; Men; Oral Contraceptives--side effects; Population; Population Characteristics; Research Methodology; Smoking; Statistical Studies; Studies; Women

Mesh:

Substances:

Year:  1979        PMID: 552294      PMCID: PMC1429714          DOI: 10.1111/j.1365-2125.1979.tb05905.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  10 in total

1.  Diphenylhydantoin dosage.

Authors:  M J Eadie; J H Tyrer; W D Hooper
Journal:  Proc Aust Assoc Neurol       Date:  1973

2.  Increased rate of clearance of drugs from the circulation of alcoholics.

Authors:  R M Kater; G Roggin; F Tobon; P Zieve; F L Iber
Journal:  Am J Med Sci       Date:  1969-07       Impact factor: 2.378

3.  Rapid determination of diphenylhydantoin in blood plasma by gas-liquid chromatography.

Authors:  J MacGee
Journal:  Anal Chem       Date:  1970-03       Impact factor: 6.986

4.  Plasma drug level monitoring in pregnancy.

Authors:  M J Eadie; C M Lander; J H Tyrer
Journal:  Clin Pharmacokinet       Date:  1977 Nov-Dec       Impact factor: 6.447

5.  Variation in response to anticonvulsants in a group of epileptic patients.

Authors:  R D Travers; E H Reynolds; B B Gallagher
Journal:  Arch Neurol       Date:  1972-07

6.  Effect of age, height, weight and sex on serum phenytoin concentration in epileptic patients.

Authors:  G W Houghton; A Richens; M Leighton
Journal:  Br J Clin Pharmacol       Date:  1975-06       Impact factor: 4.335

7.  Studies on the metabolism of diphenylhydantoin (Dilantin).

Authors:  E W LOESER
Journal:  Neurology       Date:  1961-05       Impact factor: 9.910

8.  Enhanced drug metabolism in cigarette smokers.

Authors:  P Hart; G C Farrell; W G Cooksley; L W Powell
Journal:  Br Med J       Date:  1976-07-17

9.  The metabolism of diphenylhydantoin (Dilantin) following once-daily administration.

Authors:  R A Buchanan; A W Kinkel; J R Goulet; T C Smith
Journal:  Neurology       Date:  1972-02       Impact factor: 9.910

10.  The rate of decline of diphenylhydantoin in human plasma.

Authors:  K Arnold; N Gerber
Journal:  Clin Pharmacol Ther       Date:  1970 Jan-Feb       Impact factor: 6.903

  10 in total
  6 in total

Review 1.  Pharmacokinetic drug interactions with phenytoin (Part II).

Authors:  R L Nation; A M Evans; R W Milne
Journal:  Clin Pharmacokinet       Date:  1990-02       Impact factor: 6.447

2.  Absence of effect of cigarette smoking on serum concentrations of some anticonvulsants in epileptic patients.

Authors:  P Benetello; M Furlanut; L Pasqui; L Carmillo; N Perlotto; G Testa
Journal:  Clin Pharmacokinet       Date:  1987-04       Impact factor: 6.447

3.  Metoprolol pharmacokinetics and the oral contraceptive pill.

Authors:  M J Kendall; C P Quarterman; D B Jack; L Beeley
Journal:  Br J Clin Pharmacol       Date:  1982-07       Impact factor: 4.335

Review 4.  Anticonvulsant drugs. An update.

Authors:  M J Eadie
Journal:  Drugs       Date:  1984-04       Impact factor: 9.546

Review 5.  Antiepileptic drugs. A review of clinically significant drug interactions.

Authors:  P N Patsalos; J S Duncan
Journal:  Drug Saf       Date:  1993-09       Impact factor: 5.606

6.  Hypersensitivity reaction associated with phenytoin.

Authors:  T H Indu; Roopa Satyanarayan Basutkar
Journal:  J Basic Clin Pharm       Date:  2015-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.